DE3887066D1 - Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren. - Google Patents

Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren.

Info

Publication number
DE3887066D1
DE3887066D1 DE88420340T DE3887066T DE3887066D1 DE 3887066 D1 DE3887066 D1 DE 3887066D1 DE 88420340 T DE88420340 T DE 88420340T DE 3887066 T DE3887066 T DE 3887066T DE 3887066 D1 DE3887066 D1 DE 3887066D1
Authority
DE
Germany
Prior art keywords
corticoid
impregnation
forms
galenic
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88420340T
Other languages
English (en)
Other versions
DE3887066T2 (de
Inventor
Epouse Ayache Clairet
Jean-Jacques Ayache
Georges Bruttmann
Patrick Pedrali
Serge Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medibrevex
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibrevex filed Critical Medibrevex
Application granted granted Critical
Publication of DE3887066D1 publication Critical patent/DE3887066D1/de
Publication of DE3887066T2 publication Critical patent/DE3887066T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE88420340T 1987-10-08 1988-10-07 Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren. Expired - Fee Related DE3887066T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8714476A FR2621483B1 (fr) 1987-10-08 1987-10-08 Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation

Publications (2)

Publication Number Publication Date
DE3887066D1 true DE3887066D1 (de) 1994-02-24
DE3887066T2 DE3887066T2 (de) 1994-05-11

Family

ID=9355988

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88420340T Expired - Fee Related DE3887066T2 (de) 1987-10-08 1988-10-07 Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren.

Country Status (8)

Country Link
US (1) US5061493A (de)
EP (1) EP0311540B1 (de)
JP (1) JPH01128928A (de)
AT (1) ATE99940T1 (de)
CA (1) CA1328610C (de)
DE (1) DE3887066T2 (de)
ES (1) ES2061713T3 (de)
FR (1) FR2621483B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
FR2766367B1 (fr) * 1997-07-22 2000-03-31 Plantes Et Medecines Granules homeopathiques et procede de fabrication
AU2406299A (en) * 1998-02-12 1999-08-30 Centrapharm Inc. Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
WO2005102287A2 (en) * 2004-04-22 2005-11-03 Duocort Ab Pharmaceutical compositions for acute glucocorticoid therapy
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP2910240B1 (de) * 2014-02-25 2021-07-07 Biologische Heilmittel Heel GmbH Methode zur Herstellung von Globuli

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (de) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Verfahren zur Herstellung eines trockenen, homöopathischen Heilmittels.
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
US4279900A (en) * 1978-07-13 1981-07-21 Intrex Research Corporation Prodrugs for the improved delivery of halogen-containing glucocorticosteroids
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
JPS5924964B2 (ja) * 1981-08-11 1984-06-13 帝人株式会社 徐放性製剤
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition

Also Published As

Publication number Publication date
ES2061713T3 (es) 1994-12-16
EP0311540B1 (de) 1994-01-12
CA1328610C (fr) 1994-04-19
FR2621483B1 (fr) 1991-09-20
JPH01128928A (ja) 1989-05-22
US5061493A (en) 1991-10-29
ATE99940T1 (de) 1994-01-15
DE3887066T2 (de) 1994-05-11
FR2621483A1 (fr) 1989-04-14
EP0311540A1 (de) 1989-04-12

Similar Documents

Publication Publication Date Title
ATE138565T1 (de) Galenische 2-beta-mimetik-formen für die per- und sublinguale verabreichung
NO311867B1 (no) Fremgangsmåte for kondisjonering av vannopplöselige stoffer
FI883050A0 (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
NL190812B (nl) Werkwijze voor de bereiding van 1,4-dihydropyridinederivaten met vaatverwijdende en bloeddrukverlagende werking, alsmede farmaceutische preparaten die deze derivaten omvatten.
DE3887066D1 (de) Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren.
DE69130570T2 (de) Heterozyklische verbindungen, ihre herstellung und anwendung
DE3865988D1 (de) Benzoxazol-derivate und ihre herstellung.
DK0436110T3 (da) Pancreatinpræparater
PT99775A (pt) Processo para a preparacao de novos derivados de di-hidroisoquinolina
NO167391C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske 2-aminoalkyl-1,2-benzoisothiazol-3-(2h)-on-1,1-dioxydderivater.
ES2039248T3 (es) Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion.
AR218981A1 (es) Composiciones para la regulacion del crecimiento de las plantas en base a derivados de acidos cicloalcanocarboxilicos,como sustancia activa;nuevos derivados de acidos cicloalcanocarboxilicos para esas composiciones,y procedimiento para producir dichos derivados
ATE114117T1 (de) Galenische formen von allergenen für die sublinguale verabreichung.
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
ATE1880T1 (de) Stabile valepotriat-zubereitungen und verfahren zu deren herstellung.
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
DK144417C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive alfa-(3,4-dimethoxyphenethylaminomethyl)-2-alkoxybenzylalkoholer eller farmaceutisk anvendelige syreadditionssalte deraf
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
AR209832A1 (es) Nuevos esteres de acidos n-metoxi - benzimidoiltionotiolfosforicos con propiedades insecticidas y acaricidas,composiciones insecticidas y acaricidas a base de los mismos y procedimiento para la produccion de dichos compuestos
ATE108336T1 (de) Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung.
ATE114245T1 (de) Galenische formen von gammaglobulinen für die sublinguale verabreichung.
IE38945L (en) 2-amino-3,4-dihydropyridines.
RU97112422A (ru) Способ получения средства, обладающего иммуномодулирующей активностью
ATE146788T1 (de) 4-heterocyclophenyl substituierte dihydropyridine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee